This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Healthcare Stock Q2 Earnings Roster for Aug 5: HUM, CRL & More
by Zacks Equity Research
The healthcare sector is expected to have benefited from solid demand for medical products and services in Q2, given the rising incidence of coronavirus cases as well as an ageing U.S. populace.
Humana (HUM) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Humana's (HUM) Q2 results are likely to reflect better revenues and membership growth.
Humana (HUM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Humana (HUM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molina Healthcare's Buyout Deal to Boost Its Base in Kentucky
by Zacks Equity Research
Molina Healthcare's (MOH) upcoming acquisition will fortify its presence in the Kentucky market.
Humana Ties Up With DCI's Affiliate to Serve Members With CKD
by Zacks Equity Research
Humana (HUM) ties up with DCI and its affiliate REACH Kidney Care to offer improved health outcomes for CKD patients in Alabama, North Carolina, South Carolina, and Tennessee.
Centene, Quartet Extend Ties for Mental Health Solutions
by Zacks Equity Research
Centene (CNC) and Quartet Health extend their collaboration to deliver behavioral health care services nationwide.
UnitedHealth's Unit Ties Up With Boulder Community Health
by Zacks Equity Research
UnitedHealth's (UNH) Optum reaches an agreement with Boulder Community Health to provide better medical services to communities in the Boulder County as well as its surroundings.
Why You Should Add Molina Healthcare (MOH) to Your Portfolio
by Zacks Equity Research
Riding high on its strategic initiatives and a solid top line, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
UnitedHealth's Therapy to Guide People With Type 2 Diabetes
by Zacks Equity Research
UnitedHealth (UNH) rolls out a digital health therapy - Level2, which will result in improved health outcomes for people with type 2 diabetes.
UnitedHealth (UNH) to Post Q2 Earnings: Will Revenue Rise Aid?
by Zacks Equity Research
Solid segmental revenues are likely to have aided UnitedHealth's (UNH) earnings performance in Q2.
6 Health Insurance Stocks Poised to Beat on Earnings in Q2
by Sapna Bagaria
Health insurers' second-quarter 2020 earnings results are likely to gain from lower healthcare utilization, partly offset by higher costs.
4 Telehealth Stocks to Gain on Virtual Response to Coronavirus
by Sreoshi Bera
Advancement in technology has helped cater to the growing medical demand during the coronavirus pandemic. Here are four telehealth stocks set to boom.
Will Walmart's (WMT) Foray in Health Insurance be a Bane?
by Zacks Equity Research
Walmart's (WMT) penetration in the health insurance industry may intensify competition in the profitable MA market.
Why the Earnings Surprise Streak Could Continue for Humana (HUM)
by Zacks Equity Research
Humana (HUM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Health Insurers Poised for a Bull Run in the Second Half
by Srijita Guha
We shortlist three health insurance stocks for the second half of 2020 that should enhance your portfolio, given their solid fundamentals.
The Zacks Analyst Blog Highlights: Netflix, Exxon Mobil, Amgen, Humana and FedEx
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Netflix, Exxon Mobil, Amgen, Humana and FedEx
Here's Why You Should Retain Humana (HUM) in Your Portfolio
by Zacks Equity Research
Riding high on its robust Medicare business line and strategic initiatives, Humana (HUM) holds potential to reap benefits for investors.
Teladoc (TDOC) Scales 52 Week High on InTouch Health Purchase
by Zacks Equity Research
Teladoc (TDOC) shares touch a 52-week high following the news of InTouch Health acquisition.
Molina Healthcare (MOH) Acquires to Boost Medicaid Business
by Zacks Equity Research
Molina Healthcare (MOH) buys certain assets of YourCare Health Plan to enrich its portfolio and perk up its Medicaid business.
Teladoc (TDOC) Acquires InTouch Health, Boosts Virtual Care
by Zacks Equity Research
Teladoc (TDOC) intends to offer enhanced virtual care services for clients with InTouch Health buyout.
Top Research Reports for Netflix, Exxon Mobil & Amgen
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Netflix (NFLX), Exxon Mobil (XOM) and Amgen (AMGN).
Humana's Testing Initiative to Aid Members Amid Coronavirus
by Zacks Equity Research
Humana (HUM) collaborates with Walmart, Quest, LabCorp for COVID-19 testing.
Cigna, Oscar to Launch Health Plan for Small Businesses
by Zacks Equity Research
Cigna (CI) along with Oscar unveils markets for Cigna + Oscar, aimed at aiding small businesses.
UnitedHealthcare'sTeledentistry Launch to Boost Oral Health
by Zacks Equity Research
UnitedHealth Group's (UNH) business - UnitedHealthcare - provides access to teledentistry option for its members in a bid to solve their oral health issues virtually.
Magellan Health's Initiative to Help Fight Mental Illnesses
by Zacks Equity Research
Magellan Health (MGLN) takes initiatives to help individuals combat mental health woes during the coronavirus pandemic.